NCT03646123 2025-08-28Clinical Trial of Brentuximab Vedotin in Classical Hodgkin LymphomaSeagen Inc.Phase 2 Terminated255 enrolled 29 charts
NCT01028716 2023-01-23Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesFred Hutchinson Cancer CenterPhase 2 Terminated46 enrolled 18 charts
NCT01875237 2019-07-16Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide GeneM.D. Anderson Cancer CenterPhase 1/2 Terminated3 enrolled 15 charts
NCT00281879 2017-09-27Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic CancerOHSU Knight Cancer InstitutePhase 2 Terminated200 enrolled 11 charts
NCT01076270 2017-06-28Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesFred Hutchinson Cancer CenterPhase NA Terminated1 enrolled 7 charts